GRCE: the balance sheet

MyFinsight

Grace Therapeutics, Inc. (GRCE)

Balance Sheets	2026-03-31
Cash and cash equivalents	16,977
Receivables	20
Prepaid expenses	383
Total current assets	17,380
Equipment, net	8
Intangible assets	41,128
Goodwill	8,138
Total assets	66,654

Trade and other payables	2,146
Total current liabilities	2,146
Derivative warrant liabilities	0
Deferred tax liability	612
Total liabilities	2,758
Common stock, 0.0001 par value per share 100,000,000 authorized 16,024,026 and 13,718,106 shares issued and outstanding as of march 31, 2026 and 2025, respectively	1
Additional paid-in capital	298,413
Accumulated other comprehensive loss	-6,038
Accumulated deficit	-228,480
Total stockholders equity	63,896
Total liabilities and stockholders equity	66,654

Unit: Thousand (K) dollars (except for numbers of shares and EPS).